FFA
TEVA icon

Fragasso Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Fragasso Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,156
Closed -$223K – 79
2014
Q3 		$223K Buy
4,156
+38
+0.9% +$2.01K 0.17% 72
2014
Q2 		$216K Sell
4,118
-6,695
-62% -$342K 0.19% 66
2014
Q1 		$571K Sell
10,813
-40
-0.4% -$1.85K 0.59% 44
2013
Q4 		$435K Buy
+10,853
New +$427K 0.39% 48

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fragasso Financial Advisors's TEVA Position: Q4 2014 in Review

Fragasso Financial Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2014, closing a stake of 4,156 shares — an estimated $223K sold.

Fragasso Financial Advisors first reported a position in TEVA in Q4 2013 and held it in 4 quarters. The position peaked at $571K in Q1 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

  • Fragasso Financial Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Fragasso Financial Advisors sold 4,156 Teva Pharmaceuticals shares in Q4 2014, an estimated $223K.
  • Fragasso Financial Advisors first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 4 quarters.
  • Fragasso Financial Advisors's Teva Pharmaceuticals position peaked at $571K in Q1 2014.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Fragasso Financial Advisors's 13F filing for Q4 2014, filed 21 Jan 2015.